Search

Search Constraints

You searched for: Author/Creator Raab, Marc S

Search Results

1. Elotuzumab in combination with lenalidomide and dexamethasone in patients with relapsed multiple myeloma: final phase 2 results from the randomised, open-label, phase 1b–2 dose-escalation study. Issue 12 (December 2015)

2. MOR202, a novel anti-CD38 monoclonal antibody, in patients with relapsed or refractory multiple myeloma: a first-in-human, multicentre, phase 1–2a trial. Issue 5 (May 2020)

3. Novel risk stratification algorithm for estimating the risk of death in patients with relapsed multiple myeloma: external validation in a retrospective chart review. Issue 7 (14th July 2020)

4. T cell‐based targeted immunotherapies for patients with multiple myeloma. Issue 8 (19th September 2014)